Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Pantheon International appoints new chair

(Sharecast News) - Pantheon International announced on Thursday that Tony Morgan would become chair of the board from 1 January 2026, succeeding John Singer CBE, who would retire from the role and as a non-executive director at the end of the year. The London-listed firm described Morgan, who joined the board in January this year, as a private equity specialist with senior investment experience at institutions including the Canada Pension Plan Investment Board, Onex Corporation, and Permira.

"I am delighted that Tony will become the next chair of PIN's highly talented board of directors," said outgoing chair John Singer.

"Tony has been fully and proactively involved in step three of PIN's three-step corporate strategy programme ... and he has the experience to lead its implementation."

"It has been a great honour and pleasure for me to work with such a committed board, and with our manager, and I wish the company every success in the future."

In addition to becoming chair of the board, Pantheon said Morgan would also take over as chair of the nomination and management engagement committees.

Morgan said he looked forward to continuing the firm's strategic work.

"This is a very exciting time in the evolution of the private equity industry and I look forward to working with both my board colleagues and manager Pantheon to enable PIN to continue to be successful going forwards."

At 1209 BST, shares in Pantheon International were flat at 326.5p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.